Peregrine Pharmaceuticals, Inc. has established a wholly foreign-owned enterprise (WFOE), Peregrine Beijing Pharmaceuticals Technology Development Ltd., in Beijing, China. “The Chinese pharmaceutical market is currently the ninth largest in the world and is growing rapidly, doubling in size in the past five years with continued robust expansion expected,” said Steven W. King, president and chief executive officer of Peregrine. “China therefore represents an important stra...